| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.8 |